Sign Up to like & get
recommendations!
0
Published in 2021 at "Engineering"
DOI: 10.1016/j.eng.2020.11.011
Abstract: Abstract Immunotherapy with anti-programmed cell death protein-1 (PD-1)/programmed cell death ligand-1 (PD-L1) monoclonal antibodies has become routine in the treatment of many kinds of human cancers, such as lung cancer, intestinal cancer, and melanoma. The…
read more here.
Keywords:
decoy mutant;
cell;
affinity;
cell library ... See more keywords